VandeVrede L, La Joie R, Horiki S, Mundada NS, et al. Co-pathology may impact outcomes of amyloid-targeting treatments: clinicopathological results from two patients treated with aducanumab. Acta Neuropathol 2023;146:777-781.
PMID: 37725166